scispace - formally typeset
Y

Yuying Wang

Researcher at Lanzhou University

Publications -  13
Citations -  56

Yuying Wang is an academic researcher from Lanzhou University. The author has contributed to research in topics: Chemistry & Medicine. The author has co-authored 2 publications.

Papers
More filters
Journal ArticleDOI

Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease.

TL;DR: Based on the recent research focus on the novel cholinesterase inhibitors with multiple bio-functions, a review aims at summarizing and discussing the most recent studies excavating the potential carbamate-based MTDLs with choline inhibition efficacy, to accelerate the pace of pleiotropic choline-based inhibitors for coping Alzheimer's disease as discussed by the authors .
Journal ArticleDOI

N-salicyloyl tryptamine derivatives as potential therapeutic agents for Alzheimer's disease with neuroprotective effects.

TL;DR: In this paper, a series of novel N-salicyloyl tryptamine derivatives were synthesized and their anti-AD potential was evaluated both in vitro and in vivo.
Journal ArticleDOI

Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy.

TL;DR: In this article , the authors summarized the scaffold characteristics of reported non-carbamate cholinesterase inhibitors with Aβ modulation since 2020, and understand the ingenious multifunctional drug design ideas to accelerate the pace of obtaining more efficient anti-AD drugs in the future.
Journal ArticleDOI

Carbamate-based N-Substituted tryptamine derivatives as novel pleiotropic molecules for Alzheimer's disease.

TL;DR: In this paper , a series of carbamate-based N-substituted tryptamine derivatives were designed and synthesized based on functional group combination strategy, and possessed both cholinesterase inhibition and neuroprotective effects.
Journal ArticleDOI

Characterization of the synergistic inhibitory effect of cyanidin-3-O-glucoside and catechin on pancreatic lipase.

TL;DR: In this article , the authors used affinity ultrafiltration combined with spectroscopy and molecular docking to identify novel pancreatic lipase (PL) inhibitors using affinity ultra-filtration, which can be potentially used for the development of food supplements for obesity prevention.